Research & Development: Page 94


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies McGraw-Hill’s Access Medicine Launches Online Neurology Resource McGraw-Hill Medical Publishing has released Adams and Victor’s Principles of Neurology on its AccessMedicine.com platform. Adams and Victor’s Principles of Neurology...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    In this day and age when individuals are granted almost instant cult status based on subjective, if not dubious, talent, the “star” label can sometimes lose its luster. And while we live in a cynical world, where the next American Idol is about to be crowned by millions of Americans, it’s nice to...

    By Taren Grom • Jan. 2, 2008
  • digital pill Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Avoiding Undue Influence

    Thought leaders — scientific and clinical experts — play a pivotal role in helping pharma companies identify key topics of interest to physicians. Depending on their role, these KOLs provide launch and sales support or play a critical role in continuing medical education. They provide solid, evid...

    By Autumn Konopka • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on Your Mind -- Opinions

    Alternatives to the integrated pharmaceutical company business model are taking hold as smaller players contribute to the industry’s value chain. Some of these newer players are focusing on specific areas, such as development, while others are creating hybrid models. We asked PharmaVOICE readers ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Marketplace

    Featured Product and Service Showcases Ateb Inc. BioCor Criterium Inc. DVC HealthCare Inc. The Hal Lewis Group Inc. inVentiv Health Medidata Solutions Inc. MedNet Solutions MProven LLC NXLevel Inc. Stinson Brand Innovation Inc. Sudler & Hennessey Directory of Companies by Catego...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Contracting for Clinical Success

    Contracting for Clinical Success Clinical Research VIEW on Biotech April 2006 Clinical excellence is a necessary component of any trial from Phase 1 to CTD preparation, but attention to detail is particularly important for biotechnology companies. Small- and midsize biotechnology compani...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies DataLabs Launches Products to Enhance e-CDM DataLabs has released DataLabs Clinical, a single data-management system that unifies the functionality of paper data entry (PDE) with the flexibility of electronic data capture (EDC). D...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    On the Cover Drugs in the real world There is an increasing need for more information about prescription drugs once they are approved and available to the larger marketplace. Phase IV studies have become important vehicles for postapproval risk-management and drug-safety assessment. Features The ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    Damn the Torpedoes, Full Speed Ahead Recent calls from academic ivory towers to end pharmaceutical and device company collaboration with doctors and medical centers are stupefying and potentially dangerous. Stupefying because pharmaceutical companies are often a patient’s best ally against pain, ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Birth of a New Market

    Women want more than just birth control. They are looking for additional benefits from contraceptives to meet their individual needs. By Cynthia Borda A wide choice of contraceptive products has been introduced to the market in recent years, representing innovative new products and options in bir...

    By Cynthia Borda • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Injecting a Dose of Energy Into a Vaccine Company

    By Kim Ribbink Problem solving and decision making have been at the heart of Vijay Samant’s successful career. Now the forthright President and CEO of Vical Inc. is forging ahead with ambitious plans and dynamic ideas to turn the one-time boutique research company into a leader in the field of va...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Interlink Launches Medical-Education Company Interlink Healthcare Communications has formed a medical-education entity called IneXel Medical Strategy and Communications. IneXel provides a full range of services within four major areas of me...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Value of Postmarketing Studies

    Timothy Pratt, Ph.D., Chief Marketing Officer and Principal Scientific Advisor of MedNet Solutions Inc., discusses how postmarketing research, just like everything else successful companies do, is all about marketing, and marketing is all about meeting customers’ needs. Properly constructed and e...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Phase IV studies appear to be the hottest thing in clinical research. More and more companies are fulfilling their regulatory commitments, more CROs are benefitting from the outsourced programs, and physicians have additional avenues for bolstering their resumes. But what about the patients — you...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Market for Biochips in Clinical Research Expected to expand As biochip technology makes the transition from bench to bedside in the clinical-trial process, improved patient therapies will result, according to a recent report from Frost &...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    April 2006 On the Calendar April 17-19 2006 World Health Care Congress Marriott Wardman Park Hotel, Washington, D.C. PharmaVOICE is exhibiting at this event. For more information, contact Tracey Fielding, World Congress, at 781-939-2555, e-mail [email protected], or visit worldcongress...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Shifting the Pediatrics Paradigm

    By Autumn Konopka The FDA’s push for pediatric studies since the late 1990s has nearly doubled the pediatrics market, which is expected to keep growing in the coming years. Nevertheless, children remain “therapeutic orphans,” and some experts believe that the pediatrics market may never be able t...

    By Autumn Konopka • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    Elsevier MDL Introduces Electronic Lab Notebook Elsevier MDL has launched MDL Notebook, the initial release of its major electronic lab notebook (ELN) initiative. MDL Notebook brings systematic efficiency to fundamental research activity by streamlining workflows, improving productivity, and inte...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A World Vision -- Prof. Paul Herrling

    By Kim Ribbink Paul Herrling, head of corporate research at Novartis, appreciates the multidimensionality of life, whether he is conducting experiments in the lab or overseeing corporate decisions. He extends this view to medicine while creating an environment that strives for collaboration and d...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Regulatory Deficiency is High Among Non-U.S. Clinical Investigators In a sharp reversal of previous trends, good clinical practice (GCP) deficiency rates for non-U.S.-based clinical investigators have surged past the corresponding rates for U.S.-based investigators. This is the finding of The Glo...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    the winner is … HBA 2006 Woman of the Year Susan Desmond-Hellmann, M.D., President of Product Development at Genentech, has been named the 2006 Woman of the Year by the Healthcare Businesswomen’s Association (HBA). Dr. Desmond-Hellmann is credited with possessing extraordinary leadership, unwaver...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Consumer Health Market Trends Show Continued Interest in E-Based Sources The population of consumers using the Internet as their primary learning channel for health information continued an upward trajectory in 2005, with 31.6 million consumers reporting that the Internet is their first stop when...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Drug Delivery: A Pipeline of Research and Market Opportunities

    By Denise Myshko Delivery technologies will play an increasingly important role in the drug-development process as a means to improve the efficacy of a drug; make a drug safer, more effective, or convenient; extend its patent life; or differentiate it in the marketplace. In recent years, there ha...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Cover

    The Forum for the Industry Executive Cover February 2006 Bridging the Gap Between Sales & Marketing Creating a New Culture with Hiromi Yoshikawa Advancements in Drug Delivery The Depression Market Download PDF

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...

    By PharmaVoice Team • Jan. 2, 2008